Washington D.C.— February 28, 2024. Today, the Center for Religious Expression (CRE) filed an Amicus Brief to the U.S. Supreme Court on behalf of the United States Medical Association (USMA) in the case of Food and Drug Administration (FDA), et. al v. Alliance for Hippocratic Medicine, challenging the FDA’s removal of common-sense health and safety standards for the abortion pill Mifepristone.
After approving Mifepristone – an extremely dangerous drug – under dubious circumstances, the FDA has stripped away health and safety standards for its use, putting countless women and girls in grave danger. Most notably, the FDA recently made the permanent change to allow individuals to obtain the abortion pills by mail order, eliminating the need for an in-person appointment with a physician or an ultrasound. For purely political reasons, the FDA fractured the doctor-patient relationship when it comes to Mifepristone, keeping doctors from informing their patients about the alarming dangers of this drug.
The U.S. Supreme Court is considering the propriety of the FDA’s actions in removing the health and safety standards. And as a medical society that strives to minimize external influences imposed on the practice of medicine and the doctor-patient relationship, the USMA was compelled to weigh in on this critical issue. With its amicus brief, the USMA seeks to restore the doctor-patient relationship with Mifepristone usage so women can make informed decisions about taking this harmful drug.
“We are honored to represent the USMA in this case before the Supreme Court, to give voice to physicians who serve as fiduciaries to the House of Medicine,” said CRE Chief Counsel, Nate Kellum. “Joining USMA in this fight, we cannot stand by while the FDA leaves vulnerable women in the dark for political gain.”
